Navelbine and Capecitabine (NavCap) versus NavCap Followed by Weekly Docetaxel as First-Line Treatment for Patients with HER-2 Negative Metastatic Breast Cancer

Samia Ali, Hanan Mostafa, Mohamed- Mohamed, Noha Mohamed

Oncology Research · Volume 11, Issue 12 (2015) · pp. 10–16

DOI: 10.21608/resoncol.2015.467

Abstract

No abstract

Article information

Published: 1 January 2015
Language: en
Publisher: Egypts Presidential Specialized Council for Education and Scientific Research
License: No license URL
DOI: 10.21608/resoncol.2015.467
Journal ISSN: 2357-0695